Vape waste poses risks to health and environment, analysis finds - University of Illinois Urbana-Champaign

Canadian Prime Minister Mark Carney’s “Canada Strong” strategy vows to “unite” and “secure” the nation in the face of an ongoing trade war with the U. S. Canadians are encouraged to support his efforts to “stand up to” President Donald Trump and help “build a stronger Canada.”But Carney’s united front is being tested once more, following separatist Parti Québécois’ (PQ) win in Quebec’s provincial election on Monday. The win came just two weeks before Alberta is set to vote on Oct. 19 over whether to remain in Canada or move ahead with a second binding vote on separation. The PQ has already pledged its intention to hold a referendum on Quebec independence. “The courageous battle of Francophones to protect their language and culture will succeed when they have their own country,” said Paul St-Pierre Plamondon, Quebec’s incoming Premier, during his victory speech. However, Plamondon has vowed that no such referendum will be held “as long as Trump is President of the United States,” citing the political upheaval of the trade standoff. Even if he were to change his mind, holding a referendum without a majority in Quebec’s National Assembly would prove difficult, experts say.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.